[Coronary artery ectasia and triple-vessel disease]

P Jarkovský1

  • 1Interní klinika 1. lékarské fakulty UK a UVN Praha. Patrik.Jarkovsky@email.cz

Vnitrni Lekarstvi
|February 21, 2009
PubMed

Insights

Coronary artery ectasia (CAE), a condition known since the 18th century, affects 0.2-4.9% of the population. This case report details a successful conservative management of a patient with NSTEMI, triple-vessel disease, and CAE.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Medical Imaging

Background:

  • Coronary artery ectasia (CAE) is a dilation of the coronary arteries, with reported incidence ranging from 0.2% to 4.9%.
  • Etiologies for CAE are diverse, including congenital factors, connective tissue disorders, and iatrogenic causes post-percutaneous intervention.
  • CAE frequently coexists with coronary artery disease (CAD).

Observation:

  • A case of a woman presenting with non-ST-elevation myocardial infarction (NSTEMI) as the initial manifestation of ischemic heart disease is described.
  • The patient exhibited triple-vessel disease alongside coronary artery ectasia (CAE) affecting the left anterior descending (LAD) and right coronary (RC) arteries.
  • Conservative management was implemented for this complex presentation.

Findings:

  • The conservative treatment approach yielded a positive clinical outcome for the patient with NSTEMI, triple-vessel disease, and CAE.
  • This case highlights the successful management of a patient with coexisting CAE and significant CAD.

Implications:

  • The findings suggest that conservative management can be effective for selected patients with coronary artery ectasia and ischemic heart disease.
  • Further discussion on the various treatment modalities for CAE is warranted.
  • Improved diagnostic accuracy through advanced imaging enhances the understanding of CAE prevalence and its clinical significance.

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...